Impact of a cardiovascular disease risk screening result on preventive behaviour in asymptomatic participants of the ROBINSCA trial

Abstract

Introduction

A teachable moment for preventive behavioural change can occur when asymptomatic individuals receive their cardiovascular disease screening result. This study investigated prevention-seeking behaviour and compliance with preventive treatment of participants of the population-based Risk Or Benefit IN Screening for CArdiovascular disease (ROBINSCA) trial after receiving a screening result.

Methods

Asymptomatic Dutch individuals (n = 43,447) were randomly assigned (1:1:1) to screening for cardiovascular disease by either traditional risk assessment (intervention arm A), or determining the amount of coronary artery calcification (intervention arm B), or to usual care (control arm). A random sample (n = 600) of ROBINSCA participants with a screening result (arms A and B) received an online questionnaire (in 2017) to measure the impact of a cardiovascular disease screening result in low and increased (arm A: risk > 10%; arm B: Agatston ≥ 100) risk groups.

Results

Of all respondents (438/600; 73%) 63.5% were men and the mean age ( ± standard deviation) was 63.8 ± 6.9 years. Individuals with an increased coronary artery calcification score consulted their general practitioner more often compared to increased risk individuals from arm A: 140/149 (94%) and 86/137 (62.8%), respectively (P < 0.001). Current use of blood pressure and cholesterol-lowering drugs was significantly higher in the increased coronary artery calcification score group (108/140; 77.1%), compared to the group with an increased traditional risk (35/80, 43.8%; P < 0.001). Self-reported compliance was high (98.1–100%).

Conclusion

Receiving the screening result might be a teachable moment that can enhance cardiovascular disease prevention-seeking behaviour through consulting a general practitioner and high compliance with preventive treatment. The impact of the screening result was more profound in the increased coronary artery calcification score group.

Trial registration number: NTR6471

Keywords

Cardiovascular disease coronary disease health knowledge attitudes practice mass screening randomised controlled trial treatment adherence and compliance

Get full access to this article

View all access options for this article.

References

World Health Organization. Cardiovascular diseases (CVDs). 2017 (updated 17 May 2017; cited 10 July 2018). www.who.int/en/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds) (accessed 26 March 2019).

Timmis

Townsend

Gale

et al.

Atlas Writing Group. European Society of Cardiology: Cardiovascular Disease Statistics 2017. Eur Heart J 2018; 39: 508–579.

Piepoli

Hoes

Agewall

et al.

2016 European Guidelines on cardiovascular disease prevention in clinical practice: the Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts). Developed with the special contribution of the European Association for Cardiovascular Prevention and Rehabilitation (EACPR). Eur Heart J 2016; 37: 2315–2381.

Conroy

Pyorala

Fitzgerald

et al.

Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J 2003; 24: 987–1003.

D'Agostino

Sr Vasan

Pencina

et al.

General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation 2008; 117: 743–753.

Pencina

D'Agostino

Sr D'Agostino

Jr et al.

Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med 2008; 27: 157–172. discussion 207–212.

Damen

Hooft

Schuit

et al.

Prediction models for cardiovascular disease risk in the general population: systematic review. BMJ 2016; 353: i2416.

Detrano

Guerci

Carr

et al.

Coronary calcium as a predictor of coronary events in four racial or ethnic groups. N Engl J Med 2008; 358: 1336–1345.

Erbel

Budoff

. Improvement of cardiovascular risk prediction using coronary imaging: subclinical atherosclerosis: the memory of lifetime risk factor exposure. Eur Heart J 2012; 33: 1201–1213.

10.

Kuryata

Shatailo

Horshkova

et al.

Intermediate cardiovascular risk patients in population with extremely high cardiovascular mortality: the role of coronary artery calcium scoring for risk reclassification. Eur J Prev Cardiol. 2019; 26: 885–887.

11.

Gronhoj

Gerke

Mickley

et al.

External validity of a cardiovascular screening including a coronary artery calcium examination in middle-aged individuals from the general population. Eur J Prev Cardiol 2018; 25: 1156–1166.

12.

Sillesen

Falk

. Why not screen for subclinical atherosclerosis?. Lancet 2011; 378: 645–646.

13.

Johnson

Gulanick

Penckofer

et al.

Does knowledge of coronary artery calcium affect cardiovascular risk perception, likelihood of taking action, and health-promoting behavior change?. J Cardiovasc Nurs 2015; 30: 15–25.

14.

Bosworth

Ngouyombo

Liska

et al.

The importance of cholesterol medication adherence: the need for behavioral change intervention programs. Patient Prefer Adherence 2018; 12: 341–348.

15.

Senore

Giordano

Bellisario

et al.

Population based cancer screening programmes as a teachable moment for primary prevention interventions. A review of the literature. Front Oncol 2012; 2: 45.

16.

Iaccarino

Duran

Slatore

et al.

Combining smoking cessation interventions with LDCT lung cancer screening: a systematic review. Prev Med 2019; 121: 24–32.

17.

Lawson

Flocke

. Teachable moments for health behavior change: a concept analysis. Patient Educ Couns 2009; 76: 25–30.

18.

Dutch College of General Practitioners [Nederlands Huisartsen Genootschap (NHG)]. Multidisciplinary guideline cardiovascular risk management, revision 2011 [Multidisciplinaire richtlijn Cardiovasculair risicomanagement, herziening 2011], Houten, the Netherlands: Bohn Stafleu van Loghum; 2011.

19.

Vonder

van der Aalst

Vliegenthart

et al.

Coronary artery calcium imaging in the ROBINSCA Trial: rationale, design, and technical background. Acad Radiol 2018; 25: 118–128.

20.

Nielen MMJ, van der Meer V and Schellevis FG. Evalutatie pilot PreventieConsult cardiometabool risico [Evaluation of the pilot PreventionConsult Cardiometabolic Risk]. Utrecht: NIVEL, 2010.

21.

Gupta

Lau

Varshney

et al.

The identification of calcified coronary plaque is associated with initiation and continuation of pharmacological and lifestyle preventive therapies: a systematic review and meta-analysis. JACC Cardiovasc Imaging 2017; 10: 833–842.

22.

McNaughton

Shucksmith

. Reasons for (non)compliance with intervention following identification of ‘high-risk’ status in the NHS Health Check programme. J Public Health (Oxf) 2015; 37: 218–225.

23.

Leening

Heeringa

Deckers

et al.

Healthy volunteer effect and cardiovascular risk. Epidemiology 2014; 25: 470–471.

24.

Althubaiti

. Information bias in health research: definition, pitfalls, and adjustment methods. J Multidiscip Healthc 2016; 9: 211–217.

25.

Hagger

Hardcastle

et al.

Health literacy in familial hypercholesterolemia: a cross-national study. Eur J Prev Cardiol 2018; 25: 936–943.

26.

Raz

Brown

et al.

Psychological burden associated with lung cancer screening: a systematic review. Clin Lung Cancer 2016; 17: 315–324.